Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Rebecca Zisser / Axios

Medicine is poised to be one place where AI makes a mark. In a study published this week, researchers report that a machine algorithm was as good — or better — than pathologists at detecting the spread of a type of breast cancer.

For all the talk about the promise of AI radically changing medicine, this is one of the first peer-reviewed studies to back claims that algorithms can detect abnormalities in pathology slides, says Eric Topol from the Scripps Research Institute.

The bottom line: Radiologists and pathologists are likely to be the first in medicine affected by AI. But researchers working on the technologies don't see them replacing doctors, and instead aiding them. And even that role will require more data about the impact on the medical profession and whether AIs are accurate enough to diagnose patients.

“It is the early days,” Aidoc CEO Elad Walach says. “There’s not enough research at this point. Deep learning has been commoditized generally but it hasn’t been commoditized for the medical domain. The algorithms out there aren’t good enough as is. We need a lot of R&D to make AI work in this space. It is not just plug and play.”

What’s new: Babak Ehteshami Bejnordi and his colleagues from Radboud University Medical Center in the Netherlands evaluated algorithms submitted in a competition to analyze tissue samples from the lymph nodes of breast cancer patients. (Cancer cells are most likely to spread to these nearby areas first so they're involved in determining a patient's prognosis.) They then compared the accuracy of AI diagnoses with those of pathologists in two different situations where the researchers had a gold-standard test to check both:

  1. A panel of 11 pathologists had two hours to review 129 digitized images of samples from patients who had already received a diagnosis from a pathologist.
  2. One pathologist was given unlimited time to review all the cases. (The expert took 30 hours.)

The result: The top seven algorithms — all deep learning methods, which have lately seen progress in image and pattern recognition — performed better than the pathologists in identifying the metastases, but were on par with the pathologist whose time wasn’t restricted.

Keep in mind: The time constraints put — or not — on the pathologists in the study aren't the reality in which they practice. And, the AIs detected just one type of breast cancer. "We need to see it borne out across lots of other pathologies not just lymph nodes for breast cancers," says Topol. "This is the most impressive paper yet. But there are limitations. This is done in silico and is not a real world validation."

More opinions

PathAI: Andy Beck, whose team won the AI competition in the new study and who is now CEO of PathAI, says AI’s arrival to pathology will be a transformation rather than a disruption.

Seeing it as the latter “betrays a lack of understanding of how these fields operate. There are so many things physicians do. Typically an AI does one specific thing very well. We aren’t even close to doing the whole breadth of what a physician does.”

Aidoc: This Israeli startup is developing technology that can detect visual abnormalities — whether it be a cancer, stroke, bleeding or an edema — in head and neck CT scans. Their focus right now, says Walach, is on optimizing radiologists’ workflow from the current practice of reviewing cases in order received to getting AI to flag urgent ones first.

They’re currently testing their technology in 5 U.S. sites. Early, unpublished results at one hospital found that the AI could spot an abnormal scan with 98% sensitivity compared to what clinicians call the "ground truth" (in this study, the diagnosis by three radiologists working without AI), says Walach. They will look to publish their findings soon.

Walach says, “There is a need for peer reviewed publications about the outcomes not just the accuracy of these systems, and leading companies should invest time and resources in publishing clinical evidence.”

A big challenge: Like other cancer tests, there is a risk of detecting — and then treating — a cancer that isn't there. That isn't unique to machines but "algorithms are tuned to perform at maximum sensitivity, meaning there may be false positives," says Stanford University's Daniel Rubin, who develops imaging tools for radiology. “As we introduce these technologies, if people don’t improve accuracy and there are more false positives, it will increase the cost of health care.”

Go deeper: We asked four medical experts whether AI might help their profession

Go deeper

Chauvin defense closing: "Does not have to prove his innocence"

Chauvin's defense attorney Eric Nelson opened his closing argument on Monday by reminding the jury that Derek Chauvin "does not have to prove his innocence."

Why it matters: The jury's verdict in Chauvin's murder trial is seen by advocates as one of the most crucial civil rights cases in decades.

Merrick Garland: Domestic terror is "still with us"

Photo: Kevin Dietsch/UPI/Bloomberg via Getty Images

In his first major speech, Attorney General Merrick Garland warned the nation Monday to remain vigilant against the rising threat of domestic extremism.

Why it matters: Domestic terrorism poses an "elevated threat" to the nation this year, according to U.S. intelligence. Garland has already pledged to crack down on violence linked to white supremacists and right-wing militia groups.